Baidu
map
PHARMACOGENOMICS 润色咨询

PHARMACOGENOMICS

出版年份：暂无数据 年文章数：1847 投稿命中率： 开通期刊会员，数据随心看

出版周期：Semimonthly 自引率：10.3% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1099016, encodeId=dbc210990162c, content=一般期刊要求几张图/几个表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099015, encodeId=0774109901599, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971557, encodeId=c4009e155757, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：药物基因组学<br>经验分享：2019.11.13投稿，2020.2.13修回，2020.5.23再次修回，7月份接收，总的来说还可以，不要审稿费也不要版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3621476783, createdName=fanchen8123, createdTime=Mon Jun 07 16:21:13 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973668, encodeId=d2229e36684e, content=审稿速度:1.0<br>经验分享：11月底投稿，一审1个月，12月底修回二审，5月中旬接收，6月online，编辑人很好，投稿半年。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c202039930, createdName=1891e9713cm, createdTime=Tue Jun 15 10:50:54 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923211, encodeId=f0599232111f, content=该杂志中科院2020最新分区已经掉到4区了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6772357323, createdName=122c3e01m19(暂无昵称), createdTime=Sat Feb 06 10:36:04 CST 2021, time=2021-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895813, encodeId=231689581333, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享：刚刚接受一篇，一审四个月左右，第一轮回来小修，回修后三天直接接受，还是很友好的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6772357323, createdName=122c3e01m19(暂无昵称), createdTime=Sat Oct 31 08:54:15 CST 2020, time=2020-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539932, encodeId=fe0a539932c5, content=跌跌不休，再往下，会不会破2。一年就跌下不少，哪怕0.1分，也应该值得珍惜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13801938855, createdTime=Tue Jul 18 18:36:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522257, encodeId=21fa52225edf, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：语言要求高，会进行查重, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=abcb1681410, createdName=d200778223, createdTime=Wed May 11 10:31:00 CST 2016, time=2016-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501925, encodeId=9d36501925dc, content=一审，两个多月；二审，一个月内；等待proof，4个月。主编很nice。文章，需要非常严谨，包括实验的严谨缜密验证以及语言措辞的严谨。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Mar 22 10:34:00 CST 2014, time=2014-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=478272, encodeId=92474e827266, content=偏重的研究方向：基因组学;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=470, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=null, createdTime=Wed Jun 29 15:29:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2021-12-29 学医的彭于晏

    一般期刊要求几张图/几个表？

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1099016, encodeId=dbc210990162c, content=一般期刊要求几张图/几个表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099015, encodeId=0774109901599, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971557, encodeId=c4009e155757, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：药物基因组学<br>经验分享：2019.11.13投稿，2020.2.13修回，2020.5.23再次修回，7月份接收，总的来说还可以，不要审稿费也不要版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3621476783, createdName=fanchen8123, createdTime=Mon Jun 07 16:21:13 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973668, encodeId=d2229e36684e, content=审稿速度:1.0<br>经验分享：11月底投稿，一审1个月，12月底修回二审，5月中旬接收，6月online，编辑人很好，投稿半年。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c202039930, createdName=1891e9713cm, createdTime=Tue Jun 15 10:50:54 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923211, encodeId=f0599232111f, content=该杂志中科院2020最新分区已经掉到4区了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6772357323, createdName=122c3e01m19(暂无昵称), createdTime=Sat Feb 06 10:36:04 CST 2021, time=2021-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895813, encodeId=231689581333, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享：刚刚接受一篇，一审四个月左右，第一轮回来小修，回修后三天直接接受，还是很友好的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6772357323, createdName=122c3e01m19(暂无昵称), createdTime=Sat Oct 31 08:54:15 CST 2020, time=2020-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539932, encodeId=fe0a539932c5, content=跌跌不休，再往下，会不会破2。一年就跌下不少，哪怕0.1分，也应该值得珍惜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13801938855, createdTime=Tue Jul 18 18:36:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522257, encodeId=21fa52225edf, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：语言要求高，会进行查重, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=abcb1681410, createdName=d200778223, createdTime=Wed May 11 10:31:00 CST 2016, time=2016-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501925, encodeId=9d36501925dc, content=一审，两个多月；二审，一个月内；等待proof，4个月。主编很nice。文章，需要非常严谨，包括实验的严谨缜密验证以及语言措辞的严谨。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Mar 22 10:34:00 CST 2014, time=2014-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=478272, encodeId=92474e827266, content=偏重的研究方向：基因组学;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=470, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=null, createdTime=Wed Jun 29 15:29:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2021-12-27 MS54455111222

    什么是协同作用？什么是相加作用？两者有什么区别？

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1099016, encodeId=dbc210990162c, content=一般期刊要求几张图/几个表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099015, encodeId=0774109901599, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971557, encodeId=c4009e155757, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：药物基因组学<br>经验分享：2019.11.13投稿，2020.2.13修回，2020.5.23再次修回，7月份接收，总的来说还可以，不要审稿费也不要版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3621476783, createdName=fanchen8123, createdTime=Mon Jun 07 16:21:13 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973668, encodeId=d2229e36684e, content=审稿速度:1.0<br>经验分享：11月底投稿，一审1个月，12月底修回二审，5月中旬接收，6月online，编辑人很好，投稿半年。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c202039930, createdName=1891e9713cm, createdTime=Tue Jun 15 10:50:54 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923211, encodeId=f0599232111f, content=该杂志中科院2020最新分区已经掉到4区了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6772357323, createdName=122c3e01m19(暂无昵称), createdTime=Sat Feb 06 10:36:04 CST 2021, time=2021-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895813, encodeId=231689581333, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享：刚刚接受一篇，一审四个月左右，第一轮回来小修，回修后三天直接接受，还是很友好的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6772357323, createdName=122c3e01m19(暂无昵称), createdTime=Sat Oct 31 08:54:15 CST 2020, time=2020-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539932, encodeId=fe0a539932c5, content=跌跌不休，再往下，会不会破2。一年就跌下不少，哪怕0.1分，也应该值得珍惜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13801938855, createdTime=Tue Jul 18 18:36:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522257, encodeId=21fa52225edf, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：语言要求高，会进行查重, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=abcb1681410, createdName=d200778223, createdTime=Wed May 11 10:31:00 CST 2016, time=2016-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501925, encodeId=9d36501925dc, content=一审，两个多月；二审，一个月内；等待proof，4个月。主编很nice。文章，需要非常严谨，包括实验的严谨缜密验证以及语言措辞的严谨。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Mar 22 10:34:00 CST 2014, time=2014-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=478272, encodeId=92474e827266, content=偏重的研究方向：基因组学;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=470, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=null, createdTime=Wed Jun 29 15:29:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2021-06-07 fanchen8123

    审稿速度:6.0 | 投稿命中率:50.0
    偏重的研究方向：药物基因组学
    经验分享：2019.11.13投稿，2020.2.13修回，2020.5.23再次修回，7月份接收，总的来说还可以，不要审稿费也不要版面费。

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1099016, encodeId=dbc210990162c, content=一般期刊要求几张图/几个表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099015, encodeId=0774109901599, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971557, encodeId=c4009e155757, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：药物基因组学<br>经验分享：2019.11.13投稿，2020.2.13修回，2020.5.23再次修回，7月份接收，总的来说还可以，不要审稿费也不要版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3621476783, createdName=fanchen8123, createdTime=Mon Jun 07 16:21:13 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973668, encodeId=d2229e36684e, content=审稿速度:1.0<br>经验分享：11月底投稿，一审1个月，12月底修回二审，5月中旬接收，6月online，编辑人很好，投稿半年。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c202039930, createdName=1891e9713cm, createdTime=Tue Jun 15 10:50:54 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923211, encodeId=f0599232111f, content=该杂志中科院2020最新分区已经掉到4区了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6772357323, createdName=122c3e01m19(暂无昵称), createdTime=Sat Feb 06 10:36:04 CST 2021, time=2021-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895813, encodeId=231689581333, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享：刚刚接受一篇，一审四个月左右，第一轮回来小修，回修后三天直接接受，还是很友好的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6772357323, createdName=122c3e01m19(暂无昵称), createdTime=Sat Oct 31 08:54:15 CST 2020, time=2020-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539932, encodeId=fe0a539932c5, content=跌跌不休，再往下，会不会破2。一年就跌下不少，哪怕0.1分，也应该值得珍惜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13801938855, createdTime=Tue Jul 18 18:36:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522257, encodeId=21fa52225edf, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：语言要求高，会进行查重, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=abcb1681410, createdName=d200778223, createdTime=Wed May 11 10:31:00 CST 2016, time=2016-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501925, encodeId=9d36501925dc, content=一审，两个多月；二审，一个月内；等待proof，4个月。主编很nice。文章，需要非常严谨，包括实验的严谨缜密验证以及语言措辞的严谨。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Mar 22 10:34:00 CST 2014, time=2014-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=478272, encodeId=92474e827266, content=偏重的研究方向：基因组学;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=470, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=null, createdTime=Wed Jun 29 15:29:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2021-06-15 1891e9713cm

    审稿速度:1.0
    经验分享：11月底投稿，一审1个月，12月底修回二审，5月中旬接收，6月online，编辑人很好，投稿半年。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1099016, encodeId=dbc210990162c, content=一般期刊要求几张图/几个表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099015, encodeId=0774109901599, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971557, encodeId=c4009e155757, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：药物基因组学<br>经验分享：2019.11.13投稿，2020.2.13修回，2020.5.23再次修回，7月份接收，总的来说还可以，不要审稿费也不要版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3621476783, createdName=fanchen8123, createdTime=Mon Jun 07 16:21:13 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973668, encodeId=d2229e36684e, content=审稿速度:1.0<br>经验分享：11月底投稿，一审1个月，12月底修回二审，5月中旬接收，6月online，编辑人很好，投稿半年。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c202039930, createdName=1891e9713cm, createdTime=Tue Jun 15 10:50:54 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923211, encodeId=f0599232111f, content=该杂志中科院2020最新分区已经掉到4区了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6772357323, createdName=122c3e01m19(暂无昵称), createdTime=Sat Feb 06 10:36:04 CST 2021, time=2021-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895813, encodeId=231689581333, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享：刚刚接受一篇，一审四个月左右，第一轮回来小修，回修后三天直接接受，还是很友好的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6772357323, createdName=122c3e01m19(暂无昵称), createdTime=Sat Oct 31 08:54:15 CST 2020, time=2020-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539932, encodeId=fe0a539932c5, content=跌跌不休，再往下，会不会破2。一年就跌下不少，哪怕0.1分，也应该值得珍惜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13801938855, createdTime=Tue Jul 18 18:36:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522257, encodeId=21fa52225edf, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：语言要求高，会进行查重, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=abcb1681410, createdName=d200778223, createdTime=Wed May 11 10:31:00 CST 2016, time=2016-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501925, encodeId=9d36501925dc, content=一审，两个多月；二审，一个月内；等待proof，4个月。主编很nice。文章，需要非常严谨，包括实验的严谨缜密验证以及语言措辞的严谨。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Mar 22 10:34:00 CST 2014, time=2014-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=478272, encodeId=92474e827266, content=偏重的研究方向：基因组学;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=470, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=null, createdTime=Wed Jun 29 15:29:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2021-02-06 122c3e01m19(暂无昵称)

    该杂志中科院2020最新分区已经掉到4区了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1099016, encodeId=dbc210990162c, content=一般期刊要求几张图/几个表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099015, encodeId=0774109901599, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971557, encodeId=c4009e155757, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：药物基因组学<br>经验分享：2019.11.13投稿，2020.2.13修回，2020.5.23再次修回，7月份接收，总的来说还可以，不要审稿费也不要版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3621476783, createdName=fanchen8123, createdTime=Mon Jun 07 16:21:13 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973668, encodeId=d2229e36684e, content=审稿速度:1.0<br>经验分享：11月底投稿，一审1个月，12月底修回二审，5月中旬接收，6月online，编辑人很好，投稿半年。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c202039930, createdName=1891e9713cm, createdTime=Tue Jun 15 10:50:54 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923211, encodeId=f0599232111f, content=该杂志中科院2020最新分区已经掉到4区了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6772357323, createdName=122c3e01m19(暂无昵称), createdTime=Sat Feb 06 10:36:04 CST 2021, time=2021-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895813, encodeId=231689581333, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享：刚刚接受一篇，一审四个月左右，第一轮回来小修，回修后三天直接接受，还是很友好的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6772357323, createdName=122c3e01m19(暂无昵称), createdTime=Sat Oct 31 08:54:15 CST 2020, time=2020-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539932, encodeId=fe0a539932c5, content=跌跌不休，再往下，会不会破2。一年就跌下不少，哪怕0.1分，也应该值得珍惜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13801938855, createdTime=Tue Jul 18 18:36:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522257, encodeId=21fa52225edf, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：语言要求高，会进行查重, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=abcb1681410, createdName=d200778223, createdTime=Wed May 11 10:31:00 CST 2016, time=2016-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501925, encodeId=9d36501925dc, content=一审，两个多月；二审，一个月内；等待proof，4个月。主编很nice。文章，需要非常严谨，包括实验的严谨缜密验证以及语言措辞的严谨。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Mar 22 10:34:00 CST 2014, time=2014-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=478272, encodeId=92474e827266, content=偏重的研究方向：基因组学;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=470, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=null, createdTime=Wed Jun 29 15:29:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2020-10-31 122c3e01m19(暂无昵称)

    审稿速度:3.0 | 投稿命中率:75.0
    经验分享：刚刚接受一篇，一审四个月左右，第一轮回来小修，回修后三天直接接受，还是很友好的杂志

    3

    展开3条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=1099016, encodeId=dbc210990162c, content=一般期刊要求几张图/几个表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099015, encodeId=0774109901599, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971557, encodeId=c4009e155757, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：药物基因组学<br>经验分享：2019.11.13投稿，2020.2.13修回，2020.5.23再次修回，7月份接收，总的来说还可以，不要审稿费也不要版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3621476783, createdName=fanchen8123, createdTime=Mon Jun 07 16:21:13 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973668, encodeId=d2229e36684e, content=审稿速度:1.0<br>经验分享：11月底投稿，一审1个月，12月底修回二审，5月中旬接收，6月online，编辑人很好，投稿半年。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c202039930, createdName=1891e9713cm, createdTime=Tue Jun 15 10:50:54 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923211, encodeId=f0599232111f, content=该杂志中科院2020最新分区已经掉到4区了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6772357323, createdName=122c3e01m19(暂无昵称), createdTime=Sat Feb 06 10:36:04 CST 2021, time=2021-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895813, encodeId=231689581333, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享：刚刚接受一篇，一审四个月左右，第一轮回来小修，回修后三天直接接受，还是很友好的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6772357323, createdName=122c3e01m19(暂无昵称), createdTime=Sat Oct 31 08:54:15 CST 2020, time=2020-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539932, encodeId=fe0a539932c5, content=跌跌不休，再往下，会不会破2。一年就跌下不少，哪怕0.1分，也应该值得珍惜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13801938855, createdTime=Tue Jul 18 18:36:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522257, encodeId=21fa52225edf, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：语言要求高，会进行查重, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=abcb1681410, createdName=d200778223, createdTime=Wed May 11 10:31:00 CST 2016, time=2016-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501925, encodeId=9d36501925dc, content=一审，两个多月；二审，一个月内；等待proof，4个月。主编很nice。文章，需要非常严谨，包括实验的严谨缜密验证以及语言措辞的严谨。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Mar 22 10:34:00 CST 2014, time=2014-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=478272, encodeId=92474e827266, content=偏重的研究方向：基因组学;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=470, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=null, createdTime=Wed Jun 29 15:29:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2017-07-18 13801938855

    跌跌不休，再往下，会不会破2。一年就跌下不少，哪怕0.1分，也应该值得珍惜

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1099016, encodeId=dbc210990162c, content=一般期刊要求几张图/几个表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099015, encodeId=0774109901599, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971557, encodeId=c4009e155757, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：药物基因组学<br>经验分享：2019.11.13投稿，2020.2.13修回，2020.5.23再次修回，7月份接收，总的来说还可以，不要审稿费也不要版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3621476783, createdName=fanchen8123, createdTime=Mon Jun 07 16:21:13 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973668, encodeId=d2229e36684e, content=审稿速度:1.0<br>经验分享：11月底投稿，一审1个月，12月底修回二审，5月中旬接收，6月online，编辑人很好，投稿半年。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c202039930, createdName=1891e9713cm, createdTime=Tue Jun 15 10:50:54 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923211, encodeId=f0599232111f, content=该杂志中科院2020最新分区已经掉到4区了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6772357323, createdName=122c3e01m19(暂无昵称), createdTime=Sat Feb 06 10:36:04 CST 2021, time=2021-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895813, encodeId=231689581333, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享：刚刚接受一篇，一审四个月左右，第一轮回来小修，回修后三天直接接受，还是很友好的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6772357323, createdName=122c3e01m19(暂无昵称), createdTime=Sat Oct 31 08:54:15 CST 2020, time=2020-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539932, encodeId=fe0a539932c5, content=跌跌不休，再往下，会不会破2。一年就跌下不少，哪怕0.1分，也应该值得珍惜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13801938855, createdTime=Tue Jul 18 18:36:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522257, encodeId=21fa52225edf, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：语言要求高，会进行查重, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=abcb1681410, createdName=d200778223, createdTime=Wed May 11 10:31:00 CST 2016, time=2016-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501925, encodeId=9d36501925dc, content=一审，两个多月；二审，一个月内；等待proof，4个月。主编很nice。文章，需要非常严谨，包括实验的严谨缜密验证以及语言措辞的严谨。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Mar 22 10:34:00 CST 2014, time=2014-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=478272, encodeId=92474e827266, content=偏重的研究方向：基因组学;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=470, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=null, createdTime=Wed Jun 29 15:29:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2016-05-11 d200778223

    审稿速度:3.0 | 投稿命中率:25.0
    经验分享：语言要求高，会进行查重

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1099016, encodeId=dbc210990162c, content=一般期刊要求几张图/几个表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099015, encodeId=0774109901599, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971557, encodeId=c4009e155757, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：药物基因组学<br>经验分享：2019.11.13投稿，2020.2.13修回，2020.5.23再次修回，7月份接收，总的来说还可以，不要审稿费也不要版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3621476783, createdName=fanchen8123, createdTime=Mon Jun 07 16:21:13 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973668, encodeId=d2229e36684e, content=审稿速度:1.0<br>经验分享：11月底投稿，一审1个月，12月底修回二审，5月中旬接收，6月online，编辑人很好，投稿半年。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c202039930, createdName=1891e9713cm, createdTime=Tue Jun 15 10:50:54 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923211, encodeId=f0599232111f, content=该杂志中科院2020最新分区已经掉到4区了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6772357323, createdName=122c3e01m19(暂无昵称), createdTime=Sat Feb 06 10:36:04 CST 2021, time=2021-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895813, encodeId=231689581333, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享：刚刚接受一篇，一审四个月左右，第一轮回来小修，回修后三天直接接受，还是很友好的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6772357323, createdName=122c3e01m19(暂无昵称), createdTime=Sat Oct 31 08:54:15 CST 2020, time=2020-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539932, encodeId=fe0a539932c5, content=跌跌不休，再往下，会不会破2。一年就跌下不少，哪怕0.1分，也应该值得珍惜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13801938855, createdTime=Tue Jul 18 18:36:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522257, encodeId=21fa52225edf, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：语言要求高，会进行查重, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=abcb1681410, createdName=d200778223, createdTime=Wed May 11 10:31:00 CST 2016, time=2016-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501925, encodeId=9d36501925dc, content=一审，两个多月；二审，一个月内；等待proof，4个月。主编很nice。文章，需要非常严谨，包括实验的严谨缜密验证以及语言措辞的严谨。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Mar 22 10:34:00 CST 2014, time=2014-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=478272, encodeId=92474e827266, content=偏重的研究方向：基因组学;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=470, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=null, createdTime=Wed Jun 29 15:29:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2014-03-22 匿名用户

    一审，两个多月；二审，一个月内；等待proof，4个月。主编很nice。文章，需要非常严谨，包括实验的严谨缜密验证以及语言措辞的严谨。

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1099016, encodeId=dbc210990162c, content=一般期刊要求几张图/几个表？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099015, encodeId=0774109901599, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971557, encodeId=c4009e155757, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：药物基因组学<br>经验分享：2019.11.13投稿，2020.2.13修回，2020.5.23再次修回，7月份接收，总的来说还可以，不要审稿费也不要版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3621476783, createdName=fanchen8123, createdTime=Mon Jun 07 16:21:13 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973668, encodeId=d2229e36684e, content=审稿速度:1.0<br>经验分享：11月底投稿，一审1个月，12月底修回二审，5月中旬接收，6月online，编辑人很好，投稿半年。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c202039930, createdName=1891e9713cm, createdTime=Tue Jun 15 10:50:54 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923211, encodeId=f0599232111f, content=该杂志中科院2020最新分区已经掉到4区了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6772357323, createdName=122c3e01m19(暂无昵称), createdTime=Sat Feb 06 10:36:04 CST 2021, time=2021-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895813, encodeId=231689581333, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享：刚刚接受一篇，一审四个月左右，第一轮回来小修，回修后三天直接接受，还是很友好的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6772357323, createdName=122c3e01m19(暂无昵称), createdTime=Sat Oct 31 08:54:15 CST 2020, time=2020-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539932, encodeId=fe0a539932c5, content=跌跌不休，再往下，会不会破2。一年就跌下不少，哪怕0.1分，也应该值得珍惜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13801938855, createdTime=Tue Jul 18 18:36:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522257, encodeId=21fa52225edf, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：语言要求高，会进行查重, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=abcb1681410, createdName=d200778223, createdTime=Wed May 11 10:31:00 CST 2016, time=2016-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501925, encodeId=9d36501925dc, content=一审，两个多月；二审，一个月内；等待proof，4个月。主编很nice。文章，需要非常严谨，包括实验的严谨缜密验证以及语言措辞的严谨。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=377, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Mar 22 10:34:00 CST 2014, time=2014-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=478272, encodeId=92474e827266, content=偏重的研究方向：基因组学;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=470, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=null, createdTime=Wed Jun 29 15:29:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2011-06-29 匿名用户

    偏重的研究方向：基因组学;

    0

共18条页码: 1/2页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map